Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $427 | $952 | $1,788 | $783 |
| - Cash | $172 | $171 | $137 | $188 |
| + Debt | $35 | $41 | $42 | $42 |
| Enterprise Value | $290 | $822 | $1,693 | $636 |
| Revenue | $1,435 | $1,395 | $1,533 | $1,522 |
| % Growth | 2.9% | -9% | 0.7% | – |
| Gross Profit | -$75 | -$52 | $51 | -$38 |
| % Margin | -5.2% | -3.8% | 3.3% | -2.5% |
| EBITDA | -$101 | -$95 | $7 | -$97 |
| % Margin | -7.1% | -6.8% | 0.4% | -6.3% |
| Net Income | -$110 | -$104 | $12 | -$106 |
| % Margin | -7.7% | -7.5% | 0.8% | -6.9% |
| EPS Diluted | -0.266 | -0.25 | 0.03 | -0.26 |
| % Growth | -6.4% | -933.3% | 111.5% | – |
| Operating Cash Flow | -$18 | -$35 | -$32 | $16 |
| Capital Expenditures | -$3 | -$3 | -$11 | -$12 |
| Free Cash Flow | -$21 | -$38 | -$43 | $4 |